CIK 0001628171
- Large accelerated filer
Revolution Medicines, Inc.
Sign in to watch- Ticker
- RVMD
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 472029180
- Phone
- +1 650-481-6801
- Business address
- 700 SAGINAW DR, REDWOOD CITY, CA, 94063
Securities
- RVMD Common Stock Nasdaq
- RVMDW Warrant Nasdaq
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $59,991,980
- in 20 filings, $60.0M under 10b5-1 plans
Net −$59,991,980. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 82 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2021-09-17 | Wang Xiaolin | Sale | −250 | $30.02 | $8K | 12,195 |
| 2021-09-17 | GOLDSMITH MARK A Director | Sale | −1,531 | $30.02 | $46K | 46,472 |
| 2021-09-17 | Horn Margaret A | Sale | −479 | $30.02 | $14K | 25,999 |
| 2021-06-22 | Miller Vincent A. Director | Grant or award | +3,617 | 23,750 | ||
| 2021-06-22 | Miller Vincent A. Director | Grant or award · Stock Option (Right to Buy) | +12,659 | 12,659 | ||
| 2021-06-22 | Exter Neil Director | Grant or award | +3,617 | 23,615 | ||
| 2021-06-22 | Exter Neil Director | Grant or award · Stock Option (Right to Buy) | +12,659 | 12,659 | ||
| 2021-06-22 | Borellini Flavia Director | Grant or award | +7,234 | 7,234 | ||
| 2021-06-22 | Borellini Flavia Director | Grant or award · Stock Option (Right to Buy) | +25,318 | 25,318 | ||
| 2021-02-08 | Schroeder Thilo Director | Purchase | +300,000 | $45.00 | $13.5M | 300,000 |
| 2020-07-13 | Schroeder Thilo Director | Purchase | +150,000 | $26.00 | $3.9M | 2,668,214 |
| 2020-02-18 | Schroeder Thilo Director | Conversion | +2,118,214 | 2,118,214 | ||
| 2020-02-18 | Schroeder Thilo Director | Purchase | +400,000 | $17.00 | $6.8M | 2,518,214 |
| 2020-02-18 | Schroeder Thilo Director | Conversion · Series B Preferred Stock | −1,569,539 | 0 | ||
| 2020-02-18 | Schroeder Thilo Director | Conversion · Series C Preferred Stock | −548,675 | 0 |
Page 39 of 39 · 775 trades